A Study of Endostar Combined With Chemotherapy and Immunotherapy in Lung Squamous Cell Carcinom
Status:
Recruiting
Trial end date:
2025-05-30
Target enrollment:
Participant gender:
Summary
To explore the efficacy and safety of immune checkpoint inhibitor combined with endostar and
chemotherapy in the treatment of advanced lung squamous cell carcinoma (stage IIIB-IV).